Table 2 Clinical Characteristics of Subjects

Ureum, median (min–max)

22 (4–68)

24 (10–47)

28.5 (8–76)

27 (13–81)

Creatinine, median (min–max) mg/dL

0.8 (0.3–1.2)

0.8 (0.29–1.4)

1.0 (0.4–2.2)

0.9 (0.41–2.3)

 < 1, n (%)

55 (88.7)

43 (89.6)

37 (59.7)

35 (72.9)

1.1–1.5 n (%)

7 (11.3)

5 (10.4)

19 (30.6)

11 (22.9)

 > 1.5 n (%)

0

0

6 (9.7)

2 (4.2)

eGFR, median (min–max) ml/minute/1.73m²

106.5 (62.7–169.8)

102 (60–253.4)

90.11 ± 28.67

90.48 ± 35.58

 < 60, n (%)

0

0

11 (17.7)

5 (10.4)

60–90, n (%)

14 (22.6)

14 (29.2)

18 (29)

22 (45.8)

 > 90, n (%)

48 (77.4)

34 (70.8)

33 (53.2)

21 (43.8)

Potassium, median (min–max)

4.14 (3.03–5.46)

3.9 (2.8–5.01)

3.845 (2.8–5.37)

4.0 (2.3–5.1)

Pre-chemotherapy hydration, mean ± SD

4270.95 ± 740.11

3150.63 ± 656.28

4215.32 ± 759.47

3322.34 ± 780.87